Tat-haFGF 14–154 Upregulates ADAM10 to Attenuate the Alzheimer Phenotype of APP/PS1 Mice through the PI3K-CREB-IRE1α/XBP1 Pathway

Published 2017 View Full Article

Authors

Keywords

Alzheimer’s disease, aFGF, Tat-PTD, intranasal administration, APP/PS1 mice, Aβ, ADAM10, PI3K, CREB, XBP1

Journal

Molecular Therapy-Nucleic Acids

Volume 7, Issue -, Pages 439-452

Publisher

Elsevier BV

Online

2017-05-10

DOI

10.1016/j.omtn.2017.05.004

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now